NL-OMON23570Not yet recruitingNot Applicable
Pediatric kidney transplantation: an overview of 300 recipients in 10 European centers
none0 sites300 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 300
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
Inclusion Criteria
- •Patients that received a kidney transplant in an eUROGEN center when they were under the age of 18 between 2013-2020.
Exclusion Criteria
- •Loss of follow-up
Investigators
Similar Trials
Recruiting
Not Applicable
Pediatric Kidney TransplantEnd Stage Renal DiseasePediatric ALLKidney Transplant ComplicationsNCT05977387Imagine Institute500
Unknown
Not Applicable
Predictors of Rejection in Pediatric Kidney TransplantationRejection Acute RenalNCT04292418Assiut University70
Recruiting
Phase 2
Advancing Transplantation Outcomes in ChildrenKidney TransplantNCT06055608National Institute of Allergy and Infectious Diseases (NIAID)200
Not yet recruiting
Not Applicable
Predictors of Outcome of Pediatric Renal TransplantationPediatric Renal Transplantation ComplicationNCT06708988Assiut University20
Completed
Phase 4
The aDOPT Trial (Dose Optimisation Prior to Transplant):In kidney transplantation, can pre-transplant blood levels of mycophenolic acid (MPA) help to optimise individual patient's post-transplant mycophenolate mofetil (MMF) dose to improve outcomes?End-stage kidney diseaseKidney transplantationAcute transplant rejectionDrug toxicityRenal and Urogenital - Kidney diseaseInflammatory and Immune System - Other inflammatory or immune system disordersACTRN12615000273583Murdoch Children's Research Institute56